Markets.com Logo

DCTH

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    10.3965$
  • Previous Close
    10.345$
  • 52 Week Change
    10.15$
  • Day Range
    0.05$
  • 52 Week High/Low
    8.08$ - 18.23$
  • Dividend Per Share
    --
  • Market cap
    361 M$
  • EPS
    0.07
  • Beta
    0.819
  • Volume
    --

About

DCTH.US represents the common stock of Delcath Systems, Inc., a specialty pharmaceutical company focused on the treatment of rare cancers. Delcath's primary product is CHEMOSAT®, a drug-device combination product utilizing percutaneous hepatic perfusion (PHP) to deliver high-dose chemotherapy to the liver while controlling systemic exposure. The company primarily targets intrahepatic cancers such as hepatic dominant metastatic ocular melanoma (mOM) and hepatocellular carcinoma (HCC). Delcath has struggled financially in the past, and its stock price can be highly volatile.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Please only include the main factors. Clinical Trial Results: Positive data typically drives the stock up, while negative data can cause a sharp decline.

Regulatory Approval: FDA approval of their therapies would likely cause a significant price increase.

Financial Performance: Strong revenue, profitability, and cash flow can positively affect the stock price.

Market Sentiment: Overall investor confidence and trends in the biotech sector can influence DCTH.US.

Competition: Advancements by competitors can negatively affect the price.

People Also Watch

Latest news

Stock Market Today: IonQ, Rigetti, D-Wave, What’s going on with Quantum Computing Stocks?

Stock Market Today: IonQ, Rigetti, D-Wave, What’s going on with Quantum Computing Stocks?

Ghko B|--
Gold Price Today, April 7: XAU/USD Hovers Near $4,660 Ahead of Key US Inflation Data

Gold Price Today, April 7: XAU/USD Hovers Near $4,660 Ahead of Key US Inflation Data

Ghko B|--

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--